Below are the most recent publications written about "Ventricular Fibrillation" by people in Profiles.
-
Belhassen B, Conte G, Steinberg C, Whitaker J, Khan HR, Laredo M, Doldi F, Ho R, Tadros R, Dinov B, Chorin E, Hansom S, Waintraub X, Eckardt L, Jankelson L, Peichl P, Mellor G, Sy RW, Rattanawong P, Stojkovic S, Garber L, Suna G, Kautzner J, Chan KH, Srivathsan K, Tedrow U, Havranek S, Murgatroyd F, Shauer A, Winkel BG, Page SP, Milman A, Lador A, Ayou R, Sellal JM, Chevalier P, Garc?a-Fern?ndez FJ, Reichlin T, Shah D, Nazer B, Bermudez-Jimenez F, Nagase S, Morita H, Nam GB, Pappone C, Lambiase PD, Strohmer B, Stuehlinger M, Gandjbakhch E, Schulze-Bahr E, Krahn AD, Tovia-Brodie O. Mode and Characteristics of Arrhythmia?Initiation in Idiopathic Ventricular Fibrillation: A THESIS Substudy. JACC Clin Electrophysiol. 2024 08; 10(8):1794-1809.
-
Haskell SE, Hoyme D, Zimmerman MB, Reeder R, Girotra S, Raymond TT, Samson RA, Berg M, Berg RA, Nadkarni V, Atkins DL. Association between survival and number of shocks for pulseless ventricular arrhythmias during pediatric in-hospital cardiac arrest in a national registry. Resuscitation. 2024 05; 198:110200.
-
Gray JM, Raymond TT, Atkins DL, Tegtmeyer K, Niles DE, Nadkarni VM, Pandit SV, Dewan M. Inappropriate Shock Delivery Is Common During Pediatric In-Hospital Cardiac Arrest. Pediatr Crit Care Med. 2023 08 01; 24(8):e390-e396.
-
Spears J, Kowey P. Amiodarone for the prevention of shocks and death in patients with implantable cardioverter-defibrillators: Hero or villain? Heart Rhythm. 2023 04; 20(4):510-511.
-
Ye D, Zhou W, Hamrick SK, Tester DJ, Kim CSJ, Barajas-Martinez H, Hu D, Giudicessi JR, Antzelevitch C, Ackerman MJ. Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for KCND3-Encoded Kv4.3 Gain-of-Function-Associated J-Wave Syndromes. Circ Genom Precis Med. 2022 Oct; 15(5):e003238.
-
Kantharia BK, Shah AN. Implications of "slower" ventricular tachycardia on clinical management and detection and therapy function of implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2022 08; 45(8):958-962.
-
Kantharia BK. Implantable cardioverter defibrillator shocks from ventricular tachyarrhythmias in patients with ischemic heart disease: Preventative measures, shortcomings, cost-effectiveness, and global practice perspectives. J Cardiovasc Electrophysiol. 2021 09; 32(9):2558-2566.
-
Raymond TT, Pandit SV, Griffis H, Zhang X, Hanna R, Niles DE, Silver A, Lasa JJ, Haskell SE, Atkins DL, Nadkarni VM. Effect of Amplitude Spectral Area on Termination of Fibrillation and Outcomes in Pediatric Cardiac Arrest. J Am Heart Assoc. 2021 06 15; 10(12):e020353.
-
Colangelo T, Johnson D, Ho R. Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion. Tex Heart Inst J. 2021 06 04; 48(2).
-
Rodriguez-Ruiz E, Estany-Gestal A, Hoyme DB, Nadkarni VM, Rodr?guez-N??ez A. Evidence-based defibrillation dosage for children: Is it feasible to power a reliable pediatric clinical trial or it is mission impossible? Resuscitation. 2021 05; 162:266-267.